Cargando…
Antibodies as biomarkers for cancer risk: a systematic review
Increasing evidence has linked the humoral immune response with the development of various cancers. Therefore, there is growing interest in investigating the predictive value of antibodies to assess overall and tissue site-specific cancer risk. Given the large amount of antibody types and the broad...
Autores principales: | Monroy-Iglesias, Maria J, Crescioli, Silvia, Beckmann, Kerri, Le, Nga, Karagiannis, Sophia N, Van Hemelrijck, Mieke, Santaolalla, Aida |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9307228/ https://www.ncbi.nlm.nih.gov/pubmed/35380164 http://dx.doi.org/10.1093/cei/uxac030 |
Ejemplares similares
-
Immune cell–antibody interactions in health and disease
por: Karagiannis, Sophia N, et al.
Publicado: (2022) -
Macrophages in ovarian cancer and their interactions with monoclonal antibody therapies
por: Osborn, Gabriel, et al.
Publicado: (2021) -
Mechanisms of induction of regulatory B cells in the tumour microenvironment and their contribution to immunosuppression and pro-tumour responses
por: Flores-Borja, Fabian, et al.
Publicado: (2022) -
Monoclonal Antibody Against Stromal Cell-Derived Factor 2
Publicado: (2020) -
Sex and gender in interstitial lung diseases
por: Kawano-Dourado, Leticia, et al.
Publicado: (2021)